logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12582599 B1

PDFFull Text
Date of Patent:
Mar. 24, 2026

Filed:

Jul. 07, 2022

Methods for treatment of bladder cancer with gemcitabine

Applicant:

Taris Biomedical Llc, Lexington, MA (US);

Inventors:

Dennis Giesing, Lee's Summit, MO (US);

Heejin Lee, Bedford, MA (US);

Karen Daniel, Newton, MA (US);

Assignee:

TARIS Biomedical LLC, Lexington, MA (US);

Attorney:

Morrison & Foerster LLP

Primary Examiner:

David J Blanchard

Assistant Examiner:

Ivan A Greene

Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/7068 (2006.01); A61K 45/06 (2006.01); A61M 31/00 (2006.01); A61P 13/10 (2006.01); A61P 35/00 (2006.01); C07H 19/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0034 (2013.01); A61K 9/0004 (2013.01); A61K 9/0024 (2013.01); A61K 9/0092 (2013.01); A61K 31/7068 (2013.01); A61K 45/06 (2013.01); A61M 31/002 (2013.01); A61P 13/10 (2018.01); A61P 35/00 (2018.01); C07H 19/06 (2013.01);
Abstract

Drug delivery devices and methods are provided for administering gemcitabine to a patient in need of treatment of bladder cancer by intravesically administering gemcitabine into the bladder of the patient to achieve a sustained concentration of the gemcitabine in urine in the bladder sufficient to produce a therapeutically effective concentration of the gemcitabine in the tissues of the bladder. In embodiments, the local administration into the patient's bladder is at a mean average amount of from 1 mg/day to about 300 mg/day of the gemcitabine (FBE).

Find Patent Forward Citations

Giesing, Dennis. (2026). Methods for treatment of bladder cancer with gemcitabine (U.S. Patent No. 12582599). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12582599

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…